Deakin University
Browse

Cost-Effectiveness Analysis of Sunitinib Versus Interferon Alfa for the First-Line Treatment of Advanced And/Or Metastatic Renal Cell Carcinoma in Singapore

journal contribution
posted on 2024-07-26, 02:06 authored by Sil-ling PruisSil-ling Pruis, F Pearce, MI Abdul Aziz, DB Wu, KH Ng
Cost-Effectiveness Analysis of Sunitinib Versus Interferon Alfa for the First-Line Treatment of Advanced And/Or Metastatic Renal Cell Carcinoma in Singapore

History

Journal

Value in Health

Volume

21

Pagination

S15-S15

Publisher DOI

ISSN

1098-3015

Language

eng

Publication classification

E3.1 Extract of paper

Publisher

Elsevier BV

Publication URL

Usage metrics

    Research Publications

    Categories

    Keywords

    Uncategorised value

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC